Adequacy of dialysis revisited

Kidney International

Volumn 63, Issue 4, 2003, Pages 1587-1599

  Blake, Peter G ^a,d   Harrington, John T ^b   Oreopoulos, Dimitrios ^c   Cordy, Peter ^d   Khandelwal, Mukesh ^e   Suri, Rita ⁱ   Kothari, Jatin ^f   Moist, Louise ⁱ   Lindsay, Robert ⁱ   Alsunaid, Mohammed ^g   Tziviskou, Efstathia ^h  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

^e BOMBAY HOSPITAL   (India)

^f KEM HOSPITAL   (India)

^g KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^h RED CROSS HOSPITAL   (Greece)

ⁱ London Health Sciences Centre ^*

Author keywords

Creatinine clearance; Hemodialysis; Kt V; Peritoneal dialysis; Urea reduction ratio; Uremic toxins

Indexed keywords

CALCIUM; PHOSPHATE;

ADULT; CALCIUM BLOOD LEVEL; CASE REPORT; DIABETIC NEPHROPATHY; DIALYSIS; HEMODIALYSIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FAILURE; MALE; NUTRITION; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; URINE VOLUME;

EID: 0037379332     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00891.x     Document Type: Review

References (52)

1. NATIONAL KIDNEY FOUNDATION: NKF-DOQI: Clinical Practice Guidelines for Peritoneal Dialysis Adequacy. Am J Kidney Dis 30 (Suppl 2):S67-S136, 1997
2. NATIONAL KIDNEY FOUNDATION: NKF-DOQI: Clinical Practice Guidelines for Hemodialysis Adequacy. Am J Kidney Dis (Suppl 2):S15-S66, 1997
3. BLAKE PG, BARGMAN JM, BICK J, et al: Guidelines for adequacy and nutrition in peritoneal dialysis. J Am Soc Nephrol 10 (Suppl 13):S311-S321,
4. GOLDSTEIN MB, DEZIEL C, HIRSCH DJ, et al: Clinical practice guidelines for the delivery of hemodialysis. J Am Soc Nephrol 10 (Suppl 13):S306-S310.
5. LOWRIE EG, LAIRD NM, PARKER TF, SARGENT JA: Effect of the hemodialysis prescription on patient morbidity. N Engl J Med 305:1176-1181, 1981
6. GOTCH FA, SARGENT JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28:526-534, 1985
7. OWEN WF, LEW NL, LIU W, et al: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329:1001-1006, 1993
8. HELD PJ, PORT FK, WOLFE RA, et al: The dose of hemodialysis and patient mortality. Kidney Int 50:550-556, 1996
9. PARKER TF, HUSNI L, HUANG W, et al: Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 23:670-680, 1994
10. GREENE T, GASSMAN JJ, KUSEK JW, et al, for the HEMO Study Group: Design and statistical issues of the Hemodialysis (HEMO) Study. Control Clin Trials 21:502-525, 2000
11. OREOPOULOS DG: Nephrology Forum: The optimization of continuous ambulatory peritoneal dialysis. Kidney Int 55:1131-1149, 1999
12. TEEHAN BP, SCHLIEFER CR, SIGLER MH, et al: A quantitative approach to the CAPD prescription. Perit Dial Bull 5:152-156, 1985
13. KESHAVIAH PR, NOLPH DK, VAN STONE JC: The peak concentration hypothesis: A urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis and hemodialysis. Perit Dial Int 9:257-260, 1989
14. DEPNER TA: Quantifying hemodialysis and peritoneal dialysis: Examination of the peak concentration hypothesis. Semin Dial 7:315-317, 1994
15. TEEHAN BP, SCHLIEFER CR, BROWN JM, et al: Urea kinetic analysis and clinical outcome on CAPD. A five year longitudinal study. Adv Perit Dial 6:181-185, 1990
16. BLAKE PG, SOMBOLOS K, ABRAHAM G, et al: Lack of correlation between urea kinetic indices and clinical outcomes in CAPD patients. Kidney Int 39:700-706, 1991
17. MOIST LM, PORT FK, ORZOL SM, et al: Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 11:556-564, 2000
18. CHURCHILL DN, TAYLOR DW, KESHAVIAH PR, and the CANUSA Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7:198-207, 1996
19. MAIORCA R, BRUNORI G, ZUBANI R, et al: Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients: A longitudinal study. Nephrol Dial Transplant 10:2295-2305, 1995
20. BLAKE PG: A critique of the Canada/USA (CANUSA) Peritoneal Dialysis Study. Perit Dial Int 16:243-245, 1996
21. BARGMAN JM, THORPE KE, CHURCHILL DN: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA Study. J Am Soc Nephrol 12:2158-2162, 2001
22. BLAKE PG: The relationship between peritoneal clearance and patient outcome in peritoneal dialysis patients. Adv Perit Dial 16:143-147, 2000
23. DIAZ-BUXO JA, LOWRIE EG, LEW NL, et al: Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport states and solute clearance. Am J Kidney Dis 33:523-534, 1999
24. ROCCO M, SOUCI JM, PASTEN S, MCCLELLAN WM: Peritoneal dialysis adequacy and risk of death. Kidney Int 58:446-457, 2000
25. BHASKARAN S, SCHAUBEL DE, JASSAL SV, et al: The effect of small solute clearances on survival of anuric peritoneal dialysis patients. Perit Dial Int 20:181-187, 2000
26. SZETO CC, WONG TY, CHOW KM, et al: Impact of dialysis adequacy in mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 12:355-360, 2001
27. HARTY J, BOULTON H, VENNING M, GOKAL R: Impact of increasing dialysis volume on adequacy targets: A prospective study. J Am Soc Nephrol 8:1304-1310, 1997
28. MAK SK, WONG PN, LO KT, et al: Randomized prospective study of the effect of increased dialytic dose on nutritional and clinical outcome in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 36:105-114, 2000
29. PANIAGUA R, AMATO D, VONESCH E, et al: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective randomized controlled trial. J Am Soc Nephrol 13:1307-1320, 2002
30. CHURCHILL DN: The ADEMEX Study: Make haste slowly. J Am Soc Nephrol 13:1415-1418, 2002
31. EKNOYAN G, BECK GJ, CHEUNG AK, et al: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010-2019, 2002
32. SHEMIN D, BOSTOM AB, LALIBERTY P, DWORKIN LD: Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 38:85-90, 2001
33. PORT FK, ASHBY VB, DHINGRA RK, et al: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 13:1061-1066, 2002
34. LO WK, CHENG IKP, HO WY, et al: Effect of Kt/V on CAPD survival in a prospective randomized study.
35. SPALDING EM, CHAMNEY PW, FARRINGTON K: Phosphate kinetics during hemodialysis: Evidence for biphasic regulation. Kidney Int 61:655-667, 2002
36. CHARRA B, CALEMARD D, RUFFET M, et al: Survival as an index of adequacy of dialysis. Kidney Int 41:1286-1291, 1992
37. PIERRATOS A: Nocturnal home haemodialysis: An update on a 5-year experience. Nephrol Dial Transplant 14:2835-2840, 1999
38. LINDSAY RM, HEIDENHEIM AP, LEITCH R, et al: Short daily versus long nocturnal hemodialysis. Daily/Nocturnal Dialysis Study Group. J Am Soc Artif Intern Organs 47:449-455, 2001
39. LOWRIE EG, CHERTOW GM, LEW NL, et al: The urea (clearance X dialysis time) product (Kt) as an outcome-based measure of hemodialysis dose. Kidney Int 56:729-737, 1999
40. PARFREY PS, FOLEY RN, HARNETT JD, et al: Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 49:1428-1434, 1996
41. STENVINKEL P, HEIMBURGER O, PAULTRE F, et al: Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999
42. GANESH SK, STACK AG, LEVINE NE, et al: Association of elevated serum phosphate, calcium phosphate product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2131-2138, 2001
43. FOLEY RN, PARFREY PS, HARNETT JD, et al: The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease. Am J Kidney Dis 28:53-61, 1996
44. MALLAMACI F, ZOCCALI C, TRIPEPI G, et al: Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 61:609-614, 2002
45. AMERLING R, DESIMONE L, INCIONG-REYES R, et al: Clinical experience with continuous flow and flow-through peritoneal dialysis. Semin Dial 14:388-390, 2001
46. BESARAB A, BOLTON WK, BROWNE JK, et al: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 27:584-590, 1998
47. KLAHR S, LEVEY AS, BECK G, et al: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330:877-884, 1994
48. SCHAUBEL DE, BLAKE PG, FENTON SSA: Trends in CAPD technique failure rates: Canada 1981-98. Perit Dial Int 21:365-371, 2001
49. SCRIBNER GH, OREOPOULOS DG: The hemodialysis product (HDP): A better index of dialysis adequacy than Kt/V. Dial Transplant 31:13-15, 2002
50. FENTON SS, SCHAUBEL DE, DESMEULES M, et al: Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 30:334-3442, 1997
51. COLLINS AJ, HAO W, XIA H, et al: Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 34:1065-1074, 1999
52. GOKAL R, OREOPOULOS DG: Is long-term technique survival on continuous ambulatory peritoneal dialysis possible? Perit Dial Int 16:553-555, 1996